Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Ustekinumab helped three kids with alopecia areata regrow hair.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Treating H. pylori infection might help cure alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.